# Phase 1 Study of Levocetirizine

> **NCT02447393** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 20 (actual)

## Conditions studied

- Dermatitis

## Interventions

- **DRUG:** levocetirizine
- **DRUG:** cetirizine
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT02447393
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03-18
- **Primary completion:** 2008-04-30
- **Final completion:** 2008-04-30
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2017-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02447393

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02447393, "Phase 1 Study of Levocetirizine". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02447393. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*